BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹38 Cr | ₹45 Cr | ₹38 Cr | ₹36 Cr | ₹34 Cr |
What is the latest Total Non-Current Liabilities ratio of BAL PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹38 Cr |
Mar2024 | ₹45 Cr |
Mar2023 | ₹38 Cr |
Mar2022 | ₹36 Cr |
Mar2021 | ₹34 Cr |
How is Total Non-Current Liabilities of BAL PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹38 Cr | -14.36 | |
Mar2024 | ₹45 Cr | 18.02 | |
Mar2023 | ₹38 Cr | 4.32 | |
Mar2022 | ₹36 Cr | 6.44 | |
Mar2021 | ₹34 Cr | - |
Compare Total Non-Current Liabilities of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹131.6 Cr | -3.5% | -3.1% | -31.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,666.0 Cr | -3.5% | 0% | -12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,060.0 Cr | -6.6% | -7.2% | 9.8% | Stock Analytics | |
CIPLA | ₹121,080.0 Cr | -2.8% | -5% | -7.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,605.0 Cr | -2.5% | -0.4% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,556.0 Cr | -3.8% | -0.6% | -4.2% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -3.5% |
-3.1% |
-31.8% |
SENSEX | -2.7% |
-0.5% |
-5.3% |
You may also like the below Video Courses